Pubblicazioni Scientifiche


22 mag 2023

Clinical management of melanocytic tumours

Little guidance is currently available for managing patients with melanocytic tumours

04 mag 2023

Quality of life measurement in rosacea

The European Academy of Dermatology and Venereology (EADV) Task Forces (TFs) on Quality of Life (QoL) and Patient-Oriented Outcomes and Acne

04 mag 2023

Criteria used to define tumor

Determining tumor necrosis factor-alpha inhibitors (anti-TNF-α) failure is still a challenge in the management of moderate-to-severe

04 mag 2023

Efficacy and safety of abrocitinib monotherapy in adolescents and adults

Differences in atopic dermatitis (AD) disease course and manifestation with age may extend to treatment response

17 apr 2023

Bimekizumab maintenance of response through three years

Given the chronic nature of psoriasis and the loss of response that can be observed with therapies over time

17 apr 2023

Multidisciplinary Approach to the Diagnosis

Mycosis fungoides is the most common primary cutaneous T-cell lymphoma

17 apr 2023

The impact of dupilumab

Skin barrier dysfunction plays an important role in atopic dermatitis (AD) aetiopathogenesis

31 mar 2023

Clinical Review of Mucosal Melanoma

Mucosal melanoma is a rare neoplasm. Late diagnosis is caused by occult anatomic sites and scarcity of symptoms.

31 mar 2023

S2k guidelines on the management of paraneoplastic pemphigus/paraneoplastic autoimmune

Paraneoplastic pemphigus (PNP), also called paraneoplastic autoimmune multiorgan syndrome (PAMS), is a rare autoimmune disease with mucocutaneous and multi-organ involvement

31 mar 2023

2022 European guideline for the management of balanoposthitis

This guideline is an update to the 2014 edition of the European guideline for the management of balanoposthitis

13 mar 2023

Topical treatments for Kaposi sarcoma

While treatment options exist for solitary or disseminated Kaposi sarcoma

13 mar 2023

British Association of Dermatologists guidelines for the management of people

British Association of Dermatologists guidelines for the management of people with cutaneous squamous

13 mar 2023

Development and Validation of the Morphea Activity

Morphea is an insidious inflammatory disorder of the skin and deeper tissues. Determining disease activity is challenging yet important to medical decision-making and patient outcomes

06 mar 2023

Nicotinamide for Skin-Cancer Chemoprevention

Immunosuppressed organ-transplant recipients have an increased incidence of, and mortality from, skin cancer

06 mar 2023

Wound healing and microbiome

Skin wounds are common and represent a major public health and economical problem

06 mar 2023

Monkeypox outbreak, vaccination, and treatment implications for the dermatologic patient

Rapid human-to-human transmission of monkeypox has created a public health emergency requiring prompt, multidisciplinary attention

20 feb 2023

Psoriatic Arthritis in Males and Females

To assess any differences and similarities in psoriatic arthritis (PsA) between sexes.

20 feb 2023

A Review on the Safety of Using JAK Inhibitors in Dermatology

Janus kinase (JAK) inhibitors are disease-modifying agents with efficacy in treating a spectrum of burdensome dermatologic conditions

20 feb 2023

Treatment of Severe Atopic Dermatitis with Dupilumab

Atopic dermatitis is a chronic inflammatory intensively pruritic skin disease.

30 gen 2023

Combined Use of Dermoscopy, Reflectance Confocal Microscopy

Combined Use of Dermoscopy, Reflectance Confocal Microscopy and Ex-vivo Gene Expression Profiling to Detect a Micro-melanoma Less Than 1 mm in Diameter.